Hepatitis B surface antigen (HBsAg) prevalence in Congo, Democratic Republic of the
Congo, Democratic Republic of the: Hepatitis B surface antigen (HBsAg) prevalence was 1.4% in 2024. βΌ Falling
Hepatitis B surface antigen (HBsAg) prevalence in Congo, Democratic Republic of the, 2015β2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Congo, Democratic Republic of the is 1.4%, measured in 2024. That is the lowest value across all 10 years on record.
That represents a change of down 12.5% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Congo, Democratic Republic of the peaked at 1.6% in 2015 and was at its lowest, 1.4%, in 2019.
Congo, Democratic Republic of the ranks 19th of 192 countries on this measure, in the top 10%.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.5% | 1.4% | 1.6% | 5 |
| 2020s | 1.4% | 1.4% | 1.4% | 5 |
Countries ranked near Congo, Democratic Republic of the
- 17 South Sudan, Republic of 1.7% compare
- 18 Congo, Republic of 1.6% compare
- 19 Solomon Islands 1.4% compare
- 19 Togo 1.4% compare
- 19 Lesotho, Kingdom of 1.4% compare
- 19 Mauritania, Islamic Republic of 1.4% compare
More health data for Congo, Democratic Republic of the
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Un projection of annual infant deaths, annual growth rate -1.56 % change on previous year (2100)
- Un projection of annual infant deaths 133,650 (2100)
- Heat deaths vs projected death rates 821.4 (2090)
- Deaths in armed conflicts by region 528 (2026)
- Deaths in armed conflicts by country 528 (2026)
- Age population, age 08, male, interpolated 1.66 million (2025)
- Population, male 49.6% (2025)
- Population ages 15-64, female 29.09 million (2025)
- Population ages 0-14, total 51.85 million (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Congo, Democratic Republic of the?
- Hepatitis b surface antigen (hbsag) prevalence in Congo, Democratic Republic of the was 1.4% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Congo, Democratic Republic of the?
- The highest recorded value was 1.6% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Congo, Democratic Republic of the?
- The lowest recorded value was 1.4% in 2019.
- How does Congo, Democratic Republic of the rank for hepatitis b surface antigen (hbsag) prevalence?
- Congo, Democratic Republic of the ranks 19th out of 192 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Congo, Democratic Republic of the?
- Over the last ten years it is down 12.5%. The long-run trend across the full record is falling.
- Where does this Congo, Democratic Republic of the data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV Β· JSON β 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).